Dr. Hanna Rodriguez Coleman, MD

Dr. Coleman practices at Columbia University Irving Medical Center in New York, New York.

Dr. Coleman's NPI, 1669525697, was assigned on January 21, 2007. Dr. Coleman graduated from JS Weill Medical College, Cornell University in 1996. Dr. Coleman holds New York license 207760.

Dr. Coleman's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Coleman's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Coleman is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Coleman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Coleman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Coleman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Coleman is licensed in New York.

CMS data shows 57 Medicare services from Dr. Coleman across 1 procedure code in 2024, for 50 Medicare patients. Medicare paid $2,188 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Dr. Coleman in 2024. The largest group is 75 to 84, with 23 patients. 75% of them have high blood pressure, and 64% have diabetes. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Coleman's median patient age at 70, with 59% women.

In 2024, Dr. Coleman wrote 58 Medicare Part D claims for 12 patients. 72% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $939 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Coleman for performance year 2024, reported through an alternative payment model (APM). Dr. Coleman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Coleman, published from 2018 to 2023. Dr. Coleman's most frequent co-authors are Jessica Ackert, MD, Srilaxmi Bearelly, MD and Dilsher Singh Dhoot, MD.

Dmand AI links Dr. Coleman to 1 clinical trial. Conditions studied include Diabetic Retinopathy and Diabetic Angiopathies. Open Payments lists research payments to Dr. Coleman that name 1 trial.

CMS Open Payments shows 3 general payments to Dr. Coleman from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Carl Zeiss Meditec, Inc. paid the most, $147. It also lists 1 research payment totaling $312 in 2019, naming 1 clinical trial.

Dr. Coleman graduated from JS Weill Medical College, Cornell University in 1996.